- $13.67bn
- $16.45bn
- $3.80bn
- 78
- 32
- 78
- 67
2020 January 3rd | 2021 December 31st | 2021 January 1st | 2022 December 30th | 2023 December 29th | |
---|---|---|---|---|---|
Period Length: | 53 W | 52 W | 52 W | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,264 | 3,659 | 3,148 | 3,676 | 3,799 |
Cost of Revenue | |||||
Gross Profit | 1,781 | 2,035 | 1,755 | 2,106 | 2,333 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,888 | 3,098 | 2,728 | 3,066 | 3,341 |
Operating Profit | 376 | 561 | 420 | 610 | 458 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 345 | 575 | 395 | 569 | 357 |
Provision for Income Taxes | |||||
Net Income After Taxes | 515 | 493 | 391 | 450 | 311 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 514 | 493 | 390 | 450 | 311 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 514 | 493 | 390 | 450 | 311 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.26 | 2.19 | 1.85 | 1.68 | 1.63 |